Get the Stockscreener App
2.42
4.72%
-0.12
After Hours:
2.42
Metagenomi Inc stock is traded at $2.42, with a volume of 501.61K.
It is down -4.72% in the last 24 hours and down -8.68% over the past month.
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
See More
Previous Close:
$2.54
Open:
$2.51
24h Volume:
501.61K
Relative Volume:
0.85
Market Cap:
$90.83M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.68%
1M Performance:
-8.68%
6M Performance:
+50.31%
1Y Performance:
+14.69%
1-Day Range:
$2.34
$2.55
1-Week Range:
$2.322
$2.78
52-Week Range:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
Name
Metagenomi Inc
Sector
Industry
Phone
(510) 871-4880
Address
5959 HORTON STREET, EMERYVILLE
Compare MGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
2.42 | 95.33M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Initiated | H.C. Wainwright | Buy |
| May-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-05-24 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-24 | Initiated | Chardan Capital Markets | Buy |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Mar-05-24 | Initiated | Jefferies | Buy |
| Mar-05-24 | Initiated | TD Cowen | Outperform |
| Mar-05-24 | Initiated | Wells Fargo | Overweight |
View All
Metagenomi Inc Stock (MGX) Latest News
Is Metagenomi Inc. stock gaining market shareJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Will Metagenomi Inc. stock gain from lower inflation2025 Price Momentum & Reliable Volume Spike Trade Alerts - newser.com
Is Metagenomi Inc. stock a safe haven assetWeekly Market Outlook & Smart Investment Allocation Tips - newser.com
Is Metagenomi Inc a good long term investmentEconomic Impact on Stocks & Start Building Capital with Zero Risk - earlytimes.in
Using AI based signals to follow Metagenomi Inc.July 2025 Trade Ideas & Verified Entry Point Detection - newser.com
Market reaction to Metagenomi Inc.’s recent newsBull Run & Technical Confirmation Trade Alerts - newser.com
What indicators show strength in Metagenomi Inc.2025 Momentum Check & Free Expert Verified Stock Movement Alerts - newser.com
Is Metagenomi Inc. stock a bargain at current levelsPortfolio Value Summary & High Yield Stock Recommendations - newser.com
What sentiment indicators say about Metagenomi Inc. stockEntry Point & Community Verified Trade Signals - newser.com
How to manage a losing position in Metagenomi Inc.Weekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Dropping Nvidia for Amazon's custom chips helped gene therapy startup Metagenomi cut AI bill 56% - MSN
Key resistance and support levels for Metagenomi Inc.Portfolio Growth Summary & Accurate Entry and Exit Point Alerts - newser.com
How to forecast Metagenomi Inc. trends using time seriesMarket Activity Report & Daily Oversold Bounce Ideas - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Metagenomi (NASDAQ:MGX) - MarketBeat
How to build a custom watchlist for Metagenomi Inc.Portfolio Growth Summary & Momentum Based Trading Signals - newser.com
Will Metagenomi Inc. stock go up soonProduct Launch & High Win Rate Trade Alerts - newser.com
Is Metagenomi Inc. forming a reversal patternMarket Rally & Safe Entry Trade Reports - newser.com
Exit strategy if you’re trapped in Metagenomi Inc.Market Volume Report & Growth Focused Investment Plans - newser.com
How to monitor Metagenomi Inc. with trend dashboardsRate Cut & Verified Momentum Stock Ideas - newser.com
Metagenomi Inc Stock Analysis and ForecastDebt-to-Equity Ratio Analysis & Stay One Step Ahead of Risk Events - earlytimes.in
Metagenomi Inc Stock (MGX) Financials Data
There is no financial data for Metagenomi Inc (MGX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):